Navigation Links
Blackstone Sells Gerresheimer Stake
Date:4/16/2008

DUSSELDORF, Germany, April 16 /PRNewswire-FirstCall/ -- The Blackstone Group has today informed us that it has decided to sell its close to 25% stake in Gerresheimer AG, held by BCP Murano II S.a.r.l. with immediate effect. In the course of the transaction, led by Credit Suisse, 7.8 million shares will be sold to a variety of institutional investors. Blackstone has thus decided to exit its Gerresheimer investment after Gerresheimer's IPO in June 2007. Dr. Axel Herberg, CEO of Gerresheimer AG: "Blackstone made a successful IPO possible and afforded us enormous growth opportunities. With this exit, our free float rises substantially, making our shares even more attractive to the investment community."

Gerresheimer is a pharmaceutical & life science supply and services company with market leading positions of specialty products made of glass and plastic. Gerresheimer owns 41 production sites in Europe, America and Asia and employs approximately 10,800 employees worldwide.

Contact Press

Burkhard Lingenberg

Director Corporate PR & Marketing

Telephone: +49-211-6181-250

Telefax: +49-211-6181-241

E-Mail: b.lingenberg@gerresheimer.com

Contact Investor Relations

Anke Linnartz

Director Corporate Investor Relations

Telephone: +49-211-6181-314

Telefax: +49-211-6181-121

E-Mail: a.linnartz@gerresheimer.com


'/>"/>
SOURCE Gerresheimer AG
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Isolagen, Inc. Sells Switzerland Facility
2. On The Go Healthcare Sells VAR Business to Wireless and Internet Space Development Leader FTS Group
3. Medifast Franchise Systems Sells First Territory in Baltimore
4. HLTH Corporation Sells its Minority Interest in Emdeon Business Services to General Atlantic and Hellman & Friedman for $575 Million
5. Sentillion Announces Strong Q4 Performance; Signs 10 New Customers; Sells 95,800 Licenses
6. MediPurpose Sells 500 Millionth Safety Lancet to IMCO Member MMS Medical
7. TeamStaff Sells Per Diem Business Unit
8. Turnaround Partners Sells Minority Ownership in Interactive Nutrition to Natural Nutrition
9. Informed Medical Communications Sells Consumer Internet Division to Revolution Health
10. Dragon Sells EPO Business; Focus on Antibiotic Core Business
11. NPS Sells Assets Related to mGluR Collaboration to AstraZeneca for $30 Million to Support Late-Stage Product Development
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Roper Industries Completes the Acquisition of Verathon, Inc. 2Roper Industries Completes the Acquisition of Verathon, Inc. 3Illness often undiscovered and undertreated among the uninsured 3A Harvard study 59784 1Illness often undiscovered and undertreated among the uninsured 3A Harvard study 59784 2FDA approves GlaxoSmithKlines VOTRIENT 28TM 29 for advanced renal cell cancer 5578 1FDA approves GlaxoSmithKlines VOTRIENT 28TM 29 for advanced renal cell cancer 5578 2FDA approves GlaxoSmithKlines VOTRIENT 28TM 29 for advanced renal cell cancer 5578 3FDA approves GlaxoSmithKlines VOTRIENT 28TM 29 for advanced renal cell cancer 5578 4Checkered history of mother and daughter cells explains cell cycle differences 10424 1Checkered history of mother and daughter cells explains cell cycle differences 10424 2Checkered history of mother and daughter cells explains cell cycle differences 10424 3